baber/WOPTO huggingface dataset:
Patent AU-2019424830-B2 (AU)
Title: Methods for identifying a companion animal susceptible to treatment that reduces the risk of stone formation and compositions for reducing such risk
Inventor: JEWELL DENNIS
IPC: A23K10/30
Filed: 2019-12-18
Granted: 2023-03-30
Abstract: Methods of analyzing a biological sample obtained from the feline subject for the presence of two copies of major allele G of SNP Al_212891692 and/or to the concentration of betaine and/or 2-oxoarginine in the sample are disclosed. The methods are used in methods to identify a feline subject that would benefit from a treatment that reduces risk of calcium oxalate stone formation and in methods of treating a feline subject to reduce risk of calcium oxalate stone formation The treatment on comprises administering to the feline subject a composition that comprises an effective amount of one or more of ingredients selected from the group consisting of betaine, green tea, fenugreek and tulsi. Feline food composition that comprise effective amounts of betaine, green tea, fenugreek and tulsi are disclosed.
Patent AU-2019479118-B2 (AU)
Title: Compositions and methods of treating and reducing risk of conditions associated with elevated 4-ethylphenyl sulfate
Inventor: EPHRAIM EDEN
IPC: A23K50/40
Filed: 2019-12-19
Granted: 2023-09-28
Abstract: Compositions and methods are disclosed for treating anxiety or stress in an animal, for reducing elevated levels of 4-EPS in an animal with elevated 4-EPS levels, for preventing elevated levels of 4-EPS in an animal and for promoting growth of beneficial microbes in an animal's microbiome and inhibiting growth of non-beneficial microbes. The methods comprise administering to the animal an effective amount of soy protein and vitamin C. Compositions are disclosed which comprise amounts of soy protein and vitamin C effective for use in the methods.
Patent AU-2020200705-B2 (AU)
Title: Methods and systems for identity creation, verification and management
Inventor: COSTA FAIDELLA David
IPC: G06F21/30
Filed: 2020-01-31
Granted: 2021-07-08
Abstract: A method of providing identity services, the method comprising: 
receiving, by an identity system, identity data including validated identity data of an 
identity that an identity provider has generated for an individual; 
generating, by the identity system, a transaction to store an identifier representing the 
identity data in a data structure on a ledger of a distributed ledger system; 
sending, by the identity system, the transaction to at least one node of the distributed 
ledger system; 
generating, by the identity system, an identity token incorporating the identifier stored 
in the data structure on the ledger of the distributed ledger system; and 
providing, by the identity system to a user system of the individual, the generated 
identity token.  
27579111
WO 2017/112019 PCT/US2016/055215 
1/14 
Identity 
20 Provider 
System(s) 
28 
Inrteg rated 
Identity 
System 
Identity Restricted
User Access 
Systems) System(s) 
FIG. 1 
Integrated Identity System 2_4 
/From Identity Identity 
Identity Provider Creation/ 
PrvierInterface 4-+ Modification 
System Module Module 
o/rmIdentity User Identity Identity 
id entity IInterface Access/ Element 
User Module' 4- Management 40 Repository 
System 44 Modufle 
Module 
To/From Restricted- 
Identity 
ResricedAccess sy~stemn Verification/ 
-estAcesd Interface - Access : 
-Sycste ModuLe Module 
system 4860 
FIG. 2
Patent AU-2020201804-B2 (AU)
Title: Methods for inhibiting fibrosis in a subject in need thereof
Inventor: Brunskill Nigel John
IPC: C07K16/40
Filed: 2020-03-12
Granted: 2022-06-16
Abstract: IUU222-iUoYf 
ABSTRACT 
In one aspect, the invention provides methods for treating, inhibiting, alleviating 
or preventing fibrosis in a mammalian subject suffering, or at risk of developing a disease 
or disorder caused or exacerbated by fibrosis and/or inflammation. In one embodiment, 
5 the invention provides methods of treating a subject suffering from renal fibrosis. In one 
embodiment, the invention provides methods of reducing proteinuria in a subject 
suffering from a renal disease or condition associated with proteinuria. The methods 
comprise the step of administering, to a subject in need thereof, an amount of a MASP-2 
inhibitory agent effective to inhibit MASP-2-dependent complement activation.
Patent AU-2020227124-B2 (AU)
Title: An improved metal detector
Inventor: CANDY BRUCE HALCRO
IPC: H03H7/01
Filed: 2020-09-04
Granted: 2021-10-21
Abstract: A winding of an antenna of a metal detector, the winding comprises multi-turn wire with both ends 
connected to the metal detector; and at least one resistive component for connecting a first part of the 
winding to a second part of the winding, wherein the first part or the second part are not both ends of 
the winding; and wherein the resistive component is configured to damp an internal resonance of the 
winding with an order greater than 1.
6/9 
103 105 
119 
Fig. 8 
101 
I123 
125 
Fig. 9
Patent AU-2020229608-B2 (AU)
Title: APS signaling-based video or image coding
Inventor: PALURI SEETHAL
IPC: H04N19/70
Filed: 2020-02-25
Granted: 2023-09-14
Abstract: According to the present disclosure, ALF parameters and/or LMCS parameters can be hierarchically signaled, which enables a reduction in the amount of data to be signaled for video/image coding and an increase in the coding efficiency.
Patent AU-2020294172-B2 (AU)
Title: Ice maker
Inventor: MATSUMOTO MARIKO
IPC: F25C5/06
Filed: 2020-12-21
Granted: 2022-03-17
Abstract: An ice maker includes an ice tray (19), a cooler configured to cool water in the ice 
tray (19), and a heater configured to heat ice in the ice tray (19). Afirsticemaking 
mode has a first cooling process by the cooler. In the first cooling process, water in the 
ice tray (19) is cooled ata first cooling rate. A second ice making mode has a second 
cooling process by the cooler and a heating process by the heater after the second cooling 
process. In the second cooling process, water in the ice tray (19) is cooled at a second 
cooling rate. The second cooling rate is higher than the first cooling rate.
7/14 
Fig. 9 
F2 
S114 
S115 
S116 
Ti t<-1 3°C? No 
Yes S117 S122 
S118 S123 
S119 S124 
S120 NoYes --/ 125 
Yes S121 S126 
S127 
S114 START SECOND ICE MAKING MODE 
S115 BLOWER ROTATIONAL SPEED f_Max es 
S117 BLOWER ROTATIONAL SPEED f_n 
S118 HEATER OUTPUT W_Max 
S119 START TO COUNT TIME th1 
S120 SECOND SET TIME ELAPSED? S129 
S121 STOP HEATER 
S122 REVERSE ROTATION OF ICE TRAY Yes 
S123 START TO COUNT TIME trl 
S124 FIRST SET TIME ELAPSED? No 
S125 NORMAL ROTATION OF ICE TRAY 
S126 START TO COUNT TIME tr2 Fl S127 FIRST SET TIME ELAPSED? 
S128 STOP ICE TRAY 
S129 FULL?
Patent AU-2020466063-B2 (AU)
Title: Method for designing and predicting performance of lap zones of tangential functional gradient coating based on constraints of path width and path interval
Inventor: LI FANGYI
IPC: C23C4/12
Filed: 2020-12-17
Granted: 2022-07-21
Abstract: The present invention relates to the technical field of thermal spraying, relates to a method for 
designing and predicting performance of lap zones of a tangential functional gradient coating based 
on constraints of path width and path interval, designing a reasonable lap zone structure, comprising 
the steps of: step 1: determining a distribution function of growth rate of coating and a path width; 
step 2: based on the constraints of path width and path interval, determining a multi-path interval 
overlap structure of the lap zone, specifically including determining a path interval, a lap zone width, 
and number of overlap layers; step 3: calculating an equivalent composite ratio k of a coating at each 
location in a lap zone using an area weighting method, predicting an anti-erosion performance of the 
coating at each position in the lap zone. Each area of the lap zone of the tangential functional 
gradient coating prepared by the present invention follows the consistent transition law; thereby the 
transition of anti-erosion performance of the lap zone is stable and predictable.
Patent AU-2021200963-B2 (AU)
Title: Blockout Blind System
Inventor: RIEMELMOSER JOHN
IPC: E06B9/42
Filed: 2021-02-14
Granted: 2022-01-20
Abstract: A blockout blind system includes side tracks fitted with brushes in conjunction with a 
pelmet fitted with flaps ensure no light can pass around the blind. The flaps and 
brushes have offset apertures either side of the blind to allow for airflow thus preventing 
the blind being sucked out or pushed in by open or leaking windows and air conditioning 
systems. The system also conceals the chain for operating the blind thus eliminating 
strangulation hazards for children and animals. The design allows the system to be 
fitted to existing roller blinds.
Patent AU-2021201969-B2 (AU)
Title: Process
Inventor: KELLMANN RALF
IPC: C12P17/12
Filed: 2021-03-30
Granted: 2023-02-02
Abstract: PROCESS 
ABSTRACT 
The present invention relates to processes to make neosaxitoxin, and analogues and variants 
thereof, and intermediates in the production of neosaxitoxin in recombinant host cells.  
Neosaxitoxin and the analogues and variants thereof may be used in the production of 
pharmaceutical compositions.
Patent AU-2021232723-B2 (AU)
Title: Rechargeable battery jump starting device with control switch and optical position sensing switch system
Inventor: NOOK JONATHAN LEWIS
IPC: G01D11/28
Filed: 2021-09-15
Granted: 2023-03-02
Abstract: A rechargeable battery jump starting device with a control switch (e.g. rotary 
control switch) and an optical position sensing switch system to determine the position 
of the control switch. The optical position sensing switch system includes an optical 
position sensor using optical coupling to insure the integrity of isolation on the 12V to 
24V master switch to allow for a safe and effective operation, and configured so that the 
microcontroller unit reads the position on the master switch.  
99
Patent AU-2022201047-B2 (AU)
Title: Sternal closure assembly
Inventor: LLAS VARGAS SALVADOR
IPC: A61B17/82
Filed: 2022-02-17
Granted: 2023-07-27
Abstract: A sternal closure assembly for securing first and second lateral halves of a sternum.  
The assembly includes a first sliding body having a female portion and a second 
sliding body having a male portion, the male portion being telescopically mateable 
with the female portion. The male portion is capable of being fully introduced into the 
female portion only upon there being an elastic deformation of at least a part of at 
least one of the male and female portions, the male and female portions configured 
such that when the second body is mated with the first body the elastic deformation 
results in a forceful engagement between the male and female portions and also a 
forceful engagement between a first set of non-deforming teeth extending upward 
from an interconnecting bridge member of the first sliding body and a second set of 
non-deforming teeth extending upward from an interconnecting bridge member of 
the second sliding body.  
28 
18413954_1 (GHMatters) P44157AU01
Patent AU-2022235640-B2 (AU)
Title: Configurable wireless power control and management
Inventor: DAVIS BENJAMIN
IPC: G06F13/00
Filed: 2022-09-24
Granted: 2023-09-14
Abstract: A power control device for controlling the supply of electricity to an electrical apparatus or 
system. The power control device includes a microcontroller having an operating system 
with a firmware component that has at least one sandboxed software plug-in slot for 
accepting a communications protocol software plug-in to configure the microcontroller 
according to the communications protocol of the communications protocol software plug-in.
Patent JP-3250076-B2 (JP)
Title: Manufacture of soft magnetic thin film
Inventor: YOSHIMURA SHUNICHI
IPC: H01F10/14
Filed: 2000-06-15
Granted: 2002-01-28
Abstract: PROBLEM TO BE SOLVED: To obtain a method by which a soft magnetic thin film, having a small coercive force and high rectangular hysteresis characteristic, can be manufactured. SOLUTION: In a method for manufacturing a soft magnetic thin film, the soft magnetic thin film is manufactured in such a way that a thin film containing iron is formed on a substrate by electroplating and subjected to heat treatment for a period of 0.08-1.6 seconds at a temperature of 600-800 deg.C. Consequently, the soft magnetic thin film having a coercive force of 15 Oe or lower and an aspect ratio of 70% or higher can be manufactured with an extremely short-time heat treatment. When this method is used, the soft magnetic thin film having a small coercive force and a high rectangular hysteresis characteristic can be obtained through short-time heat treatment.
Patent JP-4306955-B2 (JP)
IPC: E05B63/08
Filed: 2000-12-15
Granted: 2009-08-05
Abstract: A compression chamber (14) is formed in a housing (2) around a closing piston (5), and defined upstream by the end wall of the housing and downstream by a peripheral sealing gasket (7) carried by the piston. The closing piston has an internal passage (9) which has an inlet (9a) open into the compression chamber, and an outlet (9b) communicating with an injection outlet. The injection outlet of the connector is located downstream from the gasket which is carried by the rigid and non-deformable piston. The housing is defined in a case (1) and accessible through an injection inlet duct (3) open into the housing through the housing end wall. The housing communicates with the injection outlet. The inlet duct is designed to enable the injection head to be inserted with lateral sealing into the duct towards the housing. The piston can move in the housing and inlet duct between upstream position and downstream position. A spring (12) urges the piston towards the upstream position. The compression chamber is accessible to the liquid injected by the injection head, and communicates with the outlet of the connector. The volume of the compression chamber varies with the displacement of the closing piston so that the withdrawing of the injection head causes the volume of the compression chamber to reduce and excess liquid in the chamber is expelled towards the injection outlet.
Patent JP-4965020-B2 (JP)
IPC: G01R33/563
Filed: 1998-07-30
Granted: 2012-07-04
Abstract: This invention relates to a method of contrast agent-enhanced magnetic resonance imaging of perfusion in vasculated tissue within a human or non-human animal body in which a bolus comprising a contrast-enhancing amount of a magnetic resonance imaging contrast agent is administered into the vascular system of said body, and said body is subjected to a magnetic resonance imaging procedure whereby signals or images representative of first pass of said contrast agent bolus through tissue of interest are generated, characterised in that (i) said contrast agent is capable of exhibiting simultaneous, determinable T1 and T2* reducing effects under the imaging procedure employed and (ii) a T1-weighted imaging procedure is used (a) to visualise the first pass of said contrast agent bolus through said tissue by virtue of its signal lowering T2* effect and (b) to obtain a T1-weighted contrast agent-enhanced image of said tissue.
Patent JP-4388693-B2 (JP)
IPC: G01N33/58
Filed: 1999-01-23
Granted: 2009-12-24
Abstract: A method for analyzing a liquid test sample by electrochemiluminescence. The method includes at least one specific biochemical binding reaction that leads to the formation of a complex which contains a chemiluminescence marker and the binding of the complex to a magnetic microparticle. Detection is carried out in a measuring cell having a working electrode in order to determine the concentration of the marked microparticle. The detection cycle includes a purification step, a conditioning step, a recovery step and a measuring step. A specified potential profile is applied to the working electrode during these steps. Between the conditioning step and the recovery step, an additional potential pulse with an oxidizing and/or a reducing potential is inserted into the voltage shape of the detection cycle in order to improve the deposit of the microparticle.
Patent JP-4240814-B2 (JP)
IPC: A61K31/485
Filed: 1999-06-03
Granted: 2009-03-18
Abstract: A spill-resistant pharmaceutical formulation for oral administration from a squeezable container comprises a pharmaceutical agent in a suitable vehicle comprising a liquid base and a thickening agent, the formulation consisting of mutually compatible components and having the following properties: a viscosity within the range of about 7,500 to about 12,500 cps using a Brookfield Viscometer with a "C" spindle with Helipath movement at a spindle speed of 10 rpm and 20-25 °C, a viscometric yield value of a semisolid, a spill-resistant consistency permitting the composition to be squeezed by light manual pressure through a channel, to spread in a spoon bowl sufficiently quickly for accurate measurement, and to remain in the spoon bowl without spilling on spoon inversion, tilting at 90 degrees, and vibration, homogeneity such that the components do not separate under conditions of use, and a storage stability such that the foregoing properties are retained for at least two years shelf life. A method for producing a formulation for a spill-resistant pharmaceutical composition comprises combining a per-unit dose effective amount of a pharmaceutical agent with suitable vehicle components comprising a liquid base and a thickening agent, and testing the formulation for acceptance criteria.
Patent JP-4139080-B2 (JP)
IPC: A61H23/04
Filed: 1999-07-23
Granted: 2008-08-27
Abstract: A pneumatic system consists of an inflatable/deflatable article, for example, a compression garment ( 21 ) connected to a pump ( 20 ) by connectors (12 and 11), respectively. The connector ( 12 ) attached to the garment ( 21 ) carries an RFID transponder ( 30 ) and a corresponding radio circuit ( 31 ) is located within the pump ( 20 ). In use, the transponder ( 30 ) transmits and receives information to and from the pump radio circuit ( 31 ). The information exchanged is used by the pump control system to activate the pump and to operate the pump to provide the particular operating parameters for that garment, for example, pressure, inflation/deflation cycle, duration of treatment, etc.
Patent JP-4577992-B2 (JP)
IPC: A61K38/48
Filed: 1999-09-24
Granted: 2010-11-10
Abstract: The present invention relates to a new means for the treatment of focal ischemic cerebral infarction (ischemic stroke). It has been found that reduction of alpha<SUB>2</SUB>-antiplasmin leads to a significantly smaller focal cerebral infarct size. The invention therefore provides the use of compounds that reduce alpha<SUB>2</SUB>-antiplasmin concentration or activity in vivo, for the preparation of a therapeutical composition for the treatment of focal cerebral ischemic infarction (ischemic stroke).
Patent JP-4606585-B2 (JP)
IPC: C09D9/00
Filed: 1999-09-22
Granted: 2011-01-05
Abstract: The present invention is directed to a composition for stripping coatings from a surface, the composition including: a. A solvent mixture composed of a phenyl substituted alkyl alcohol and an alkyl or aryl glycol ether or an alkyl or aromatic alcohol; b. A coupler composed of a salt formed from a water soluble organic amine and an acid comprising at least one C7-C18 ethoxylated anionic surfactant; c. Optionally water. The use of the C7-C18 ethoxylated anionic surfactant provides a stripper which can be diluted in water of various compositions yet provide an effective stripping/cleaning agent.
Patent JP-4254062-B2 (JP)
IPC: G11B17/028
Filed: 1999-12-10
Granted: 2009-04-15
Abstract: The invention relates to a recording or reproduction apparatus with a holding and removing device for disc-type recording media which facilitates the emplacement and removal of the recording medium. According to the invention, the holding and removing device is formed by a cover of the hub of the disc turntable, by means of which, during the emplacement or removal of the recording medium, the holding force with which a recording medium is held on the disc turntable is reduced. The loading on the recording medium during emplacement or removal is thereby advantageously reduced and the special configuration of the cover as restoring means has the result that no additional individual parts are necessary. In an advantageous manner, the recording medium is both held and centered on the disc turntable with a force which is greater than a resistance encountered by the recording medium during emplacement or removal. The field of application of the invention extends to recording or reproduction apparatuses with a holding and removing device-provided on the disc turntable-for the disc-type recording media, such as, for example, CD, CD-ROM or DVD drives.
Patent JP-4197848-B2 (JP)
IPC: B63B25/08
Filed: 2000-04-27
Granted: 2008-12-17
Abstract: The transfer device between a jib including at least one pipe section (54a, 54b) fixed to the jib (12) and a coupling, comprises a system of concertina or deformable diamond-shaped type articulated pipe segments and actuated by cable, at least one pipe section (24a, 24b) connecting to the coupling means. Each section fixed to the jib or connecting to the coupling is connected to one end of the system by a bend and rotary joints (53a, 53b), the bend being fixed to a support (51, 52) suspended from the jib. Each end of the system is fixed to a support (74a) movably mounted in rotation by a bearing (78a) on the bend support to which the end is connected, concentrically with the joint (72a) connecting the end to the bend. The invention applies in particular to the transfer of liquefied natural gas from a marine platform to an oil tanker.
Patent JP-4643024-B2 (JP)
IPC: C07D239/36
Filed: 2000-05-02
Granted: 2011-03-02
Abstract: The invention relates to compounds of the general formulawhereinR1 is unsubstituted or mono- to penta-substituted aryl, whereby the substituents are selected from the group consisting for instance of OH, Halogen, CN, C1-C6-alkyl, optionally substituted C3-C8-cycloalkyl and optionally substituted C3-C8-cycloalkenyl;A is for instance a single bond, C1-C12-alkylene or O;X1 and X2, independently of one another, are R10; X3 is H or R10;R10 is for instance halogen, CN, NO2, C1-C6-alkyl, C3-C8-cycloalkyl or C1-C6-haloalkyl;R21 and R22, independently of one another are for instance H, halogen, CN, NO2, OH, SH, C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-alkyl-C3-C8-cycloalkyl or C3-C8-cycloalkyl-C1-C6-alkyl;R23 and R24, independently of one another, are for instance H, C1-C6-alkyl, C3-C8-cycloalkyl, C3-C8-cycloalkyl-C1-C6-alkyl, C1-C6-haloalkyl or C3-C8-halocycloalkyl;m is 1, 2, 3 or 4; andn is 0, 1 or 2;as well as the physiologically acceptable addition compounds, a method of producing these compounds and the usage of these compounds, pesticide compositions whose active ingredient is chosen from these compounds, each in free form or in agrochemically employable salt form, and a method of producing and using these compositions. The active ingredients, in free form or in agrochemically employable salt form, have advantageous pesticidal properties. The are especially suitable for the control of pests in agriculture and in storage, as well as in the care of domestic animals.